These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30115681)

  • 21. MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling.
    Deliz-Aguirre R; Cao F; Gerpott FHU; Auevechanichkul N; Chupanova M; Mun Y; Ziska E; Taylor MJ
    J Cell Biol; 2021 Jul; 220(7):. PubMed ID: 33956941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Polymorphisms in IRAK1, IRAK4 and MyD88, and Severe Invasive Pneumococcal Disease.
    Carrasco-Colom J; Jordan I; Alsina L; Garcia-Garcia JJ; Cambra-Lasaosa FJ; Martín-Mateos MA; Juan M; Muñoz-Almagro C
    Pediatr Infect Dis J; 2015 Sep; 34(9):1008-13. PubMed ID: 26075815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRAK4 turns IL-10+ phospho-FOXO+ monocytes into pro-inflammatory cells by suppression of protein kinase B.
    Over B; Ziegler S; Foermer S; Weber AN; Bode KA; Heeg K; Bekeredjian-Ding I
    Eur J Immunol; 2013 Jun; 43(6):1630-42. PubMed ID: 23519847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4.
    Alsina L; Israelsson E; Altman MC; Dang KK; Ghandil P; Israel L; von Bernuth H; Baldwin N; Qin H; Jin Z; Banchereau R; Anguiano E; Ionan A; Abel L; Puel A; Picard C; Pascual V; Casanova JL; Chaussabel D
    Nat Immunol; 2014 Dec; 15(12):1134-42. PubMed ID: 25344726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling.
    Li Y; Shah RB; Sarti S; Belcher AL; Lee BJ; Gorbatenko A; Nemati F; Yu H; Stanley Z; Rahman M; Shao Z; Silva JM; Zha S; Sidi S
    Sci Signal; 2023 Dec; 16(816):eadh3449. PubMed ID: 38113335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the protein kinases that activate the E3 ubiquitin ligase Pellino 1 in the innate immune system.
    Goh ET; Arthur JS; Cheung PC; Akira S; Toth R; Cohen P
    Biochem J; 2012 Jan; 441(1):339-46. PubMed ID: 22007846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
    Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
    J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
    Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
    Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
    Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
    J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic analysis of immunodeficiency.
    Tough DF
    Nat Immunol; 2014 Dec; 15(12):1097-8. PubMed ID: 25396343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4).
    Wang L; Ferrao R; Li Q; Hatcher JM; Choi HG; Buhrlage SJ; Gray NS; Wu H
    J Biol Chem; 2019 Mar; 294(12):4511-4519. PubMed ID: 30679311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.
    Bennett J; Ishikawa C; Agarwal P; Yeung J; Sampson A; Uible E; Vick E; Bolanos LC; Hueneman K; Wunderlich M; Kolt A; Choi K; Volk A; Greis KD; Rosenbaum J; Hoyt SB; Thomas CJ; Starczynowski DT
    Blood; 2023 Sep; 142(11):989-1007. PubMed ID: 37172199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness.
    Qin J; Jiang Z; Qian Y; Casanova JL; Li X
    J Biol Chem; 2004 Jun; 279(25):26748-53. PubMed ID: 15084582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional characterization of three myeloid differentiation factor 88 (MyD88) isoforms from thick shell mussel Mytilus coruscus.
    Guo B; Liu S; Li J; Liao Z; Liu H; Xia H; Qi P
    Fish Shellfish Immunol; 2018 Dec; 83():123-133. PubMed ID: 30205204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mmm-derived lipid-associated membrane proteins activate IL-1β production through the NF-κB pathway via TLR2, MyD88, and IRAK4.
    Wang Y; Wang Q; Li Y; Chen Y; Shao J; Nick N; Li C; Xin J
    Sci Rep; 2017 Jun; 7(1):4349. PubMed ID: 28659605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma.
    Chen Y; Bai G; Ning Y; Cai S; Zhang T; Song P; Zhou J; Duan W; Ding J; Xie H; Zhang H
    Eur J Med Chem; 2020 Mar; 190():112092. PubMed ID: 32014679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
    Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
    J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease.
    Staschke KA; Dong S; Saha J; Zhao J; Brooks NA; Hepburn DL; Xia J; Gulen MF; Kang Z; Altuntas CZ; Tuohy VK; Gilmour R; Li X; Na S
    J Immunol; 2009 Jul; 183(1):568-77. PubMed ID: 19542468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of high mobility group B1 and toll-like receptor-nuclear factor κB signaling pathway in chronic subdural hematomas.
    Osuka K; Watanabe Y; Usuda N; Iwami K; Miyachi S; Takayasu M
    PLoS One; 2020; 15(6):e0233643. PubMed ID: 32479555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.